Cannabis stocks surge on rescheduling news; Aurora Cannabis jumps 16% despite no US strategy. Read why I'm maintaining my ...

Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the launch of Whistler Cannabis Co. in Australia. As one of Canada's original ...

U.S. President Donald Trump's administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ...

Aurora Cannabis (ACB) announces the launch of Whistler Cannabis Co. in Australia. As one of Canada’s original cannabis brands, with a proud ...

Greetings and welcome to Aurora Cannabis Incorporated Fiscal First Quarter 2026 Results Conference Call all participants will ...

Tilray stock surged 14.13% after hours as reports of a possible marijuana reclassification by Trump fueled investor optimism.

U.S. President Donald Trump’s administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ...

The stock's rise snapped a three-day losing streak.

ACB's global medical cannabis momentum stays strong, but near-term regulatory headwinds might have limited Q1 revenue upside.

Aurora Cannabis Inc (ACB) reports significant revenue increases and maintains a robust cash position, despite challenges in ...